Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2009
03/17/2009US7504392 2,3,4,5-tetrahydro-1H-3-benzazepines and their medical use
03/17/2009US7504391 Analogues of N-methyl, hydroxy(alkoxy)-partially saturated indeno(1,2-a)-3-benzoazeines, naphtho(1,2-a)-3-benzoazepines, and 1-phenyl-3-benzazepenes; metabolic disorders/eating disorders, e.g., obesity (dietetics), hyperphagia; antidiabetic agents; obsessive compulsive, somatoform dissociative disorders
03/17/2009US7504362 Pesticidal compositions
03/17/2009US7504162 Heat resistance; forming film
03/17/2009CA2340405C Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same
03/17/2009CA2337849C Piperazinone derivatives and applications thereof
03/17/2009CA2316351C Benzopyran and benzothiopyran derivatives having retinoid antagonist-like activity
03/12/2009WO2009032703A1 2- (het) arylamino-6-aminopyridine derivatives and fused forms thereof as anaplastic lymphoma kinase inhibitors
03/12/2009WO2009032668A2 2 -biphenylamino-4 -aminopyrimidine derivatives as kinase inhibitors
03/12/2009WO2009032326A1 New tetracycline derivatives as antiinfective agents
03/12/2009WO2009032277A1 Gamma secretase modulators
03/12/2009WO2009032249A1 Soluble guanylate cyclase activators
03/12/2009WO2009032124A1 Substituted indole derivatives and methods of use thereof
03/12/2009WO2009032116A1 2, 3-substituted indole derivatives for treating viral infections
03/12/2009WO2009030952A2 Phenylcarboxamide derivatives as inhibitors and effectors of the hedgehog pathway
03/12/2009WO2009030106A1 7-(4-oximino-3-amino-1-piperidyl)quinolinecarboxylic acid derivatives and their preparation methods
03/12/2009WO2009029998A1 Retrometabolic compounds
03/12/2009WO2009010478A8 Use of piperidine derivatives as agonists of chemokine receptor activity
03/12/2009WO2009010139A3 Quinazolinamide derivatives
03/12/2009WO2009002229A3 New anticoagulant compounds, pharmaceutical compositions on their basis to treat thrombotic conditions, and plasma-substituting solution to correct hypercoagulation defects of hemodilution
03/12/2009WO2009002228A3 New thrombin function compounds and pharmaceutical compositions based on them
03/12/2009WO2008155668A3 Heteroarylamide pyrimidone compounds
03/12/2009WO2008145524A3 4,4-disubstituted piperidine derivatives
03/12/2009WO2008132600A3 Trpv1 antagonists and uses thereof
03/12/2009WO2008116185A3 Substituted pyrimidines as adenosine receptor antagonists
03/12/2009WO2007092681A3 Piperidinyl derivatives as modulators of chemokine receptor activity
03/12/2009US20090069565 New indole derivatives as factor xa inhibitors
03/12/2009US20090069564 Methods and Compositions for Selectin Inhibition
03/12/2009US20090069559 Compositions and methods for modulating sirtuin activity
03/12/2009US20090069558 Oxidatively cyclized tetrahydrobilene
03/12/2009US20090069379 Deuterium-enriched lenalidomide
03/12/2009US20090069377 Deuterium-enriched enzastaurin
03/12/2009US20090069376 Substituted N [N-(sulphonylphenyl)sulfonyl-prolyl]-phenylalanine derivatives are antagonists of the very late antigen-4 integrin; ulcerative colitis, Crohn's disease, asthma, multiple sclerosis, rheumatoid arthritis
03/12/2009US20090069373 Quinoline Acids
03/12/2009US20090069370 Azacyclylisoquinolinone and isoindolinone derivatives as histamine-3 antagonists
03/12/2009US20090069360 Organic Compounds
03/12/2009US20090069352 Deuterium-enriched clazosentan
03/12/2009US20090069342 1-N-amino-2-imidazolidinones and derivatives thereof which are effective as Kv1.5 potassium channel inhibitors providing atrial-selective antiarrhythmic agents; 1-(aminosulfonylamino)-3-[2-(4-methoxyphenyl)ethyl]-4-(3,4-dimethylphenyl)-2-imidazolidinone
03/12/2009US20090069340 Pyrazolone Compounds As Metabotropic Glutamate Receptor Agonists For The Treatment Of Neurological And Psychiatric Disorders
03/12/2009US20090069339 Deuterium-enriched ciprofloxacin
03/12/2009US20090069338 Method for predicting skin sensitizing activity of compounds
03/12/2009US20090069337 3' substituted compounds having 5-ht6 receptor affinity
03/12/2009US20090069332 Novel pyridazine derivatives and medicines containing the same as effective ingredients
03/12/2009US20090069329 Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
03/12/2009US20090069328 Alpha-alkyl substituted n-acyltryptophanols
03/12/2009US20090069326 (R)-3-{3,5-Dichloro-4'-[4-(2-fluoro-ethyl)-piperazine-1-carbonyl]-biphenyl-4-ylmethyl}-1-(4,4-difluoro-cyclohexyl)-pyrrolidin-2-one, used for the treatment of diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome and cognitive disorders
03/12/2009US20090069321 Cyanomethyl substituted n-acyl tryptamines
03/12/2009US20090069316 Novel quinoline derivatives
03/12/2009US20090069314 Hydroxyalkyl Substituted Imidazoquinoline Compounds and Methods
03/12/2009US20090069310 Anti-inflammatory medicaments
03/12/2009US20090069305 Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor
03/12/2009US20090069300 Isoquinolinyl and isoindolinyl derivatives as histamine-3 antagonists
03/12/2009US20090069293 Succinoylamino benzodiazepines as inhibitors of ab protein production
03/12/2009US20090069284 Substituted 3-alkyl and 3-alkenyl azetidine derivatives
03/12/2009US20090069282 Alkyne compounds with mch antagonistic activity and medicaments comprising these compounds
03/12/2009US20090069245 Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof
03/12/2009US20090069179 Pyridin-4-ylmethylamides
03/12/2009US20090068585 Dissolution promoter and photoresist composition including the same
03/12/2009US20090068577 Naphthalenetetracarboxylic acid diimide derivative and electrophotographic photoconductor having the same
03/12/2009US20090068144 Tetrahydro-isoquinolin-1-ones for the treatment of cancer
03/12/2009US20090066231 Electroluminescent device
03/12/2009US20090066225 Aromatic amine derivative and organic electroluminescence device utilizing the same
03/12/2009CA2698742A1 Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
03/12/2009CA2698511A1 Substituted pyrimidinyl-amines as protein kinase inhibitors
03/12/2009CA2698341A1 Gamma secretase modulators
03/12/2009CA2697454A1 2-carboxy substituted indole derivatives and methods of use thereof
03/12/2009CA2697375A1 2, 3-substituted indole derivatives for treating viral infections
03/12/2009CA2696824A1 Compounds and compositions as kinase inhibitors
03/12/2009CA2684037A1 Compounds with anti-cancer activity
03/11/2009EP2034000A2 Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds
03/11/2009EP2033959A1 Tetrahydropyranoquinoline derivatives
03/11/2009EP2033956A1 A new class of histone deacetylase inhibitors
03/11/2009EP2033954A1 6-(heterocycle-substituted benzyl)-4-oxoquinoline compound and use of the same as hiv integrase inhibitor
03/11/2009EP2033953A1 Vanilloid receptor modulators
03/11/2009EP2033952A1 Nitrogen-containing Heteroaryl compounds having HIV Integrase Inhibitory Activity
03/11/2009EP2033951A2 2-Piperazine-pyridines useful for treating pain
03/11/2009EP2033637A1 Therapeutic or prophylactic agent for leukemia
03/11/2009EP2032639A2 Pyridinium salts for polymer composites and methods for their preparation
03/11/2009EP2032557A2 Methods for preparing eszopiclone
03/11/2009EP2032556A1 Anthranilic acid diamide derivative with hetero-aromatic and hetero-cyclic substituents
03/11/2009EP2032555A1 Pyrrole derivatives with crth2 receptor modulator activity
03/11/2009EP2032554A1 Piperidinyl pyrimidine derivatives
03/11/2009EP2032543A1 2-anilino-4-aminoalkyleneaminopyrimidines
03/11/2009EP2032542A2 Heterocyclic aspartyl protease inhibitors
03/11/2009EP2032541A2 Novel viral replication inhibitor
03/11/2009EP1879580B1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
03/11/2009EP1814877B1 Diphenyl substituted alkanes as flap inhibitors
03/11/2009EP1753758B1 Mercaptoimidazoles as ccr2 receptor antagonists
03/11/2009EP1517919B1 Marked peptides having affinity for a phospholipid and uses
03/11/2009EP1485364B1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
03/11/2009EP1456182B1 Pyrimidine derivatives as modulators of insuline-like growth factor-1 receptor (igf-i)
03/11/2009EP1358165B1 Imidazole derivatives
03/11/2009EP1349840B1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
03/11/2009EP1319659B1 Triazinones and medicinal use thereof
03/11/2009EP1317445B1 Chemokine receptor binding heterocyclic compounds
03/11/2009EP1175399B1 Inhibitors of c-jun n-terminal kinases (jnk)
03/11/2009EP0976722B1 Benzamidine derivatives
03/11/2009CN101384584A Crystal form of besipirdine chlorhydrate, process preparation and use thereof
03/11/2009CN101384583A Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
03/11/2009CN101384582A Piperazine compounds useful as antagonists of C-C chemokines (CCR2B and CCR5) for the treatment of inflammatory diseases